The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.

The Health and Human Services Department is considering cuts to HIV prevention funding, according to The Wall Street Journal.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced new data from two implementation studies showing zero cases of HIV ...

The plans could be announced as soon as within a day, people familiar with the matter said, if the administration goes ahead.

The Truth Awards has become a signature event in the Black LGBTQ+ community, providing a platform for celebration, empowerment and recognition. Hamilton and Holmes said that as the event continues to ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

Gilead Sciences stock declined Wednesday after The Wall Street Journal reported the Department of Health and Human Services ...

Nineties rapper, and the first lady of No Limit Records, Mia X, has earned a honorary doctorate and is now called Dr. Mia X ...

Garges, M.D. MPH., Chief Medical Officer at ViiV Healthcare, said: "As the leaders in long-acting injectables for HIV, we're committed to collecting data to understand the effectiveness of these ...

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of ...

New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...